Trofe-Clark, Jennifer <br/><br/>
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  03 2018 
 - 315-326 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6838 
<br/><br/><label>Standard No.: </label>10.1053/j.ajkd.2017.07.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--genetics<br/>Area Under Curve<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP3A--drug effects<br/>Delayed-Action Preparations--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Graft Rejection<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--pharmacokinetics<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Pharmacogenetics<br/>Postoperative Care--methods<br/>Prognosis<br/>Prospective Studies<br/>Risk Assessment<br/>Tacrolimus--pharmacokinetics<br/>Treatment Outcome